Stocks · NYSE · Healthcare · United States
RMD — Resmed Inc.
Resmed Inc. (RMD) is a healthcare stock listed on NYSE (United States). At the close of September 29, 2026 it traded at 222.83 (+0.33% on the day), -7.2% over one month, +11.1% over three months, -16.9% over twelve months. The InvestMuse composite score is +81 on a −100 to +100 scale, a strong bullish read that ranks #12 of about 1,221 assets. The strongest of its nine dimensions are Sector edge (+84) and Fundamentals (+77); the weakest is Technical indicators (-1). Its volatility regime from the hidden Markov model is Calm. 59 news articles in the last 30 days carried an average tone of +0.18 (on −1 to +1).
The facts
| Last close | 222.83 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | +0.33% / -7.2% / +11.1% / -16.9% |
| 52-week range | 182.30 – 280.31 |
| Composite score | +81 / 100 · strong bullish view · rank #12 |
| Volatility regime (HMM) | Calm |
| Resistance levels | 215.00, 255.00 |
| Trailing P/E | 18.5 |
| Market cap | $28.3B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)+75
- Technical indicators-1
- Trend+12
- Support / resistance0
- Fundamentals+77
- Sector edge+84
- News sentiment+19
- Momentum+4
- Chart patterns and zones+10
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.